Skip to content
Disclosery

Ulys, L.L.C.

Follow

13F filer, CIK 1340098, NEW YORK, NY

Ulys, L.L.C. reported $13,007,000 across 1 holding for the quarter ended 2019-09-30, in a 13F-HR filed 2019-11-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001340098-19-000011

Period
2019-09-30
Reported value
$13M
Holdings
1
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2019

Share positions as resolved from 13F-HR 0001340098-19-000011, largest first. % of portfolio is the value over $13,007,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LXRXLEXICON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: restricted; 2018Q2: restricted; 2018Q3: restricted; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: 4,321,214 shares; 2019Q3: 4,321,214 shares 4,321,214$13M100%0Timeline

How Q3 2019 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001340098-19-000011 base2019-11-14acceptance time not in the bulk data set